Bushman Julie L 4
4 · BIO-TECHNE Corp · Filed Nov 3, 2025
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Bushman Julie L
Director
Transactions
- Award
Common Stock
2025-10-30+1,640→ 8,775 total - Award
Stock Options (Right to Buy)
2025-10-30+3,777→ 3,777 totalExercise: $60.96Exp: 2035-10-30→ Common Stock (3,777 underlying)
Holdings
- 6,028
Stock Options (Right to Buy)
Exercise: $63.92From: 2021-10-28Exp: 2030-10-29→ Common Stock (6,028 underlying) - 2,532
Stock Options (Right to Buy)
Exercise: $128.81From: 2022-10-27Exp: 2031-10-28→ Common Stock (2,532 underlying) - 3,511
Stock Options (Right to Buy)
Exercise: $68.37From: 2025-10-24Exp: 2034-10-24→ Common Stock (3,511 underlying) - 1,444
Stock Options (Right to Buy)
Exercise: $69.72From: 2021-10-29Exp: 2030-07-31→ Common Stock (1,444 underlying) - 3,460
Stock Options (Right to Buy)
Exercise: $73.94From: 2023-10-26Exp: 2032-10-27→ Common Stock (3,460 underlying) - 3,937
Stock Options (Right to Buy)
Exercise: $61.51From: 2024-10-24Exp: 2033-10-26→ Common Stock (3,937 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.